EquiNet Equitable Life's advisor site

Site Search

696 results for go now MAKEMUR.COM Paying to get my daughter out of jail now pay later Leyte Regional Prison

  1. EZ Upload
  2. [pdf] Levelize the tax on fixed income investments with corporately-owned participating whole life (corpor
  3. Equitable Savings & Retirement Webcast featuring Payout Annuities

    This month, Equitable® highlights payout annuities. We will talk about life annuities, product features, taxation and the benefits that payout annuities can bring to a client’s retirement plan.

    Join your host, Deedra Weinstein, Head of S&R Product and Marketing, as she welcomes Nicole Lemon, Product Manager, Savings and Retirement, on Wednesday, November 27, 2024, at 2:00 p.m. ET / 11:00 a.m. PT.

    Learn more

    Continuing Education Credits
    This webcast has been accredited for continuing education (CE) credits for all provinces excluding Quebec via the Insurance Council of Manitoba and Alberta Insurance Council. To be eligible for CE credits, you must register individually, watch the webcast in full and complete a short quiz. This webcast is available in English only.

    Date posted: November 14, 2024

  4. Juvenile insurance is a gift that keeps on giving
    Life insurance may not come wrapped with a ribbon, but it can be a perfect gift to provide a child with a lifetime of protection. Equimax® whole life insurance provides permanent coverage, with several benefits:

    • Insurability – lock in permanent insurance protection for life while a child is young and healthy.
    • Affordability – it is cost-effective to purchase a life insurance policy for a child and lock in a guaranteed premium at children’s rates.
    • Cash value – Equimax has a guaranteed minimum cash value outlined in the contract. It can also accumulate tax-advantaged, non-guaranteed dividends1. As the cash value of the policy increases over time, the child can use the cash value to help pay for life’s milestones or emergencies.   

    Protecting a child’s future with life insurance today can be a gift that keeps on giving for all their tomorrows.

    Ask your wholesaler about Equimax whole life insurance for children.

    1Dividends are not guaranteed and are paid at the sole discretion of the Board of Directors.



     
  5. EZ Upload
  6. Resource Hub
  7. [pdf] DSC and Transfer Fee Reimbursement Request
  8. Accepted Payment Methods
  9. Policy endorsement: Contracts and group benefits plan booklet updates related to BC PharmaCare Biosi

    As we announced in the June 2019 issue of eNews, BC PharmaCare recently introduced a new Biosimilars Initiative that ends coverage of three biologic drugs, including Remicade, Enbrel, and Lantus. These drugs will no longer be eligible in British Columbia for most conditions for which lower-cost biosimilar versions are available. Patients in the province with these conditions will be required to switch to biosimilar versions of these drugs by Nov. 25, 2019 in order to maintain their coverage under BC PharmaCare.
     
    The following table outlines the affected originator drugs and their biosimilars.
     

    Drug Originator Biosimilar
    etanercept Enbrel® Brenzys®
    Erelzi™
    infliximab Remicade® Inflectra®
    Renflexis®
    insulin glargine Lantus® Basaglar™

     
    Biologics are drugs that are engineered using living organisms, such as yeast and bacteria. Biosimilars are highly similar to the originator drugs they are based on and most have been shown to have no clinically meaningful differences in safety or efficacy.
     
    To ensure this provincial change doesn’t result in your clients' plans paying additional drug costs, we are aligning our drug eligibility for these three biologic drugs with that of BC PharmaCare.
     
    To facilitate this change, we are amending some of the wording in our contracts and booklets, effective Oct. 1, 2019. Below are links to the Endorsement to the Master Policy and the Summary of Master Booklet Wording Changes for those amendments. Please download and save these policy endorsement documents for your files.
     
    In addition, please remind your clients to provide their plan members with a copy of the Summary of Master Booklet Wording Changes. The next time your clients amend their benefits plans, the updated wording will be included in their group benefits plan booklets

    DOWNLOAD ENDORSEMENT TO THE MASTER POLICY

    DOWNLOAD SUMMARY OF MASTER BOOKLET WORDING CHANGES

    As of Nov. 25, 2019, Remicade and Enbrel will no longer be eligible for BC plan members with conditions for which lower-cost biosimilar versions of the drugs are available. These plan members will be required to switch to the biosimilar versions of these drugs in order to maintain eligibility on the Equitable Life drug plan.
     
    We will be communicating with affected claimants in the coming weeks to allow them ample time to change their prescription and avoid any interruptions in their treatment or their coverage.
     
    We intend to take a similar approach to Lantus. However, we are still investigating the options to implement this change. We will be communicating with you in the coming weeks to confirm our approach for this drug.
     
    If you have any questions about this change, please contact your Group Marketing Manager or myFlex Sales Manager.
     

    ® and ™ denote trademarks of their respective owners

  10. Policy Loan